AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer: GELATO-trial

Trial Profile

AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer: GELATO-trial

Recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Nov 2017

At a glance

  • Drugs Atezolizumab (Primary) ; Carboplatin (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Acronyms GELATO-trial
  • Most Recent Events

    • 15 Nov 2017 Status changed from not yet recruiting to recruiting.
    • 13 Sep 2017 Planned initiation date changed from 1 Jul 2017 to 1 Oct 2017.
    • 12 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top